Scarica l'app Stockscreener
1.4584
0.58%
0.0084
Precedente Chiudi:
$1.45
Aprire:
$1.45
Volume 24 ore:
38,768
Relative Volume:
0.33
Capitalizzazione di mercato:
$41.27M
Reddito:
$48.20M
Utile/perdita netta:
$-35.05M
Rapporto P/E:
-0.9305
EPS:
-1.5673
Flusso di cassa netto:
$-13.02M
1 W Prestazione:
+4.17%
1M Prestazione:
-16.66%
6M Prestazione:
-17.14%
1 anno Prestazione:
-37.41%
Intervallo 1D:
$1.4009
$1.48
Intervallo di 1 settimana:
$1.2488
$1.61
Portata 52W:
$1.06
$4.35
Celularity Inc Stock (CELU) Company Profile
Nome
Celularity Inc
Settore
Industria
Telefono
(908) 768-2170
Indirizzo
170 PARK AVE, FLORHAM PARK
Confronta CELU con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CELU
Celularity Inc
|
1.4567 | 41.08M | 48.20M | -35.05M | -13.02M | -1.5673 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.31 | 115.75B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.55 | 80.71B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
408.16 | 52.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
849.21 | 52.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.63 | 37.29B | 447.02M | -1.18B | -906.14M | -6.1812 |
Celularity Inc Stock (CELU) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-01-30 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-12-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-06-22 | Iniziato | H.C. Wainwright | Buy |
| 2022-04-06 | Downgrade | Truist | Buy → Hold |
| 2022-01-28 | Iniziato | Oppenheimer | Outperform |
| 2021-11-24 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Celularity Inc Borsa (CELU) Ultime notizie
Is Celularity Inc. Equity Warrant stock a smart buy before Fed meetingJuly 2025 Big Picture & Fast Gaining Stock Strategy Reports - bolumsonucanavari.com
Why Celularity Inc. Equity Warrant stock could rally in 20252025 Price Action Summary & Verified Swing Trading Watchlist - DonanımHaber
Celularity Shareholders Reject Expansion of Equity Incentive Plan - The Globe and Mail
Can Celularity Inc. stock deliver surprise earnings beatJuly 2025 Earnings & AI Enhanced Trading Alerts - Улправда
Will Celularity Inc. stock outperform tech sector in 20252025 Volatility Report & Free High Accuracy Swing Entry Alerts - Улправда
Why Celularity Inc. Equity Warrant stock could benefit from AI revolutionJuly 2025 Fed Impact & High Accuracy Swing Trade Signals - ulpravda.ru
Celularity raises $12m to sharpen longevity strategy - Longevity.Technology
What Wall Street predicts for Celularity Inc. Equity Warrant stock priceAnalyst Downgrade & Real-Time Sentiment Analysis - DonanımHaber
Is Celularity Inc. Equity Warrant stock dividend yield sustainable2025 Market Outlook & AI Based Buy and Sell Signals - DonanımHaber
Why Celularity Inc. stock is favored by top institutionsStop Loss & Weekly Watchlist for Hot Stocks - DonanımHaber
Will Celularity Inc. Equity Warrant stock outperform Dow Jones indexPortfolio Risk Report & Risk Controlled Swing Alerts - DonanımHaber
Performance Recap: Will Celularity Inc. stock outperform tech sector in 2025Weekly Trade Summary & Growth Focused Stock Reports - moha.gov.vn
Why Celularity Inc. stock is favored by pension funds2025 Risk Factors & Precise Buy Zone Identification - Улправда
Celularity Reaches Binding Term Sheets on Financing Transactions to Support Its Strategic Vision - Investing News Network
Celularity secures up to $12 million in financing for longevity focus - Investing.com
Celularity Inc. Secures Up to $12 Million in Financing to Advance Strategic Priorities in Longevity and Human Performance - Quiver Quantitative
DoubleLine co-founder backs up to $12M funding plan for longevity - Stock Titan
Celularity Inc.'s (NASDAQ:CELU) 25% Dip In Price Shows Sentiment Is Matching Revenues - 富途牛牛
Celularity Inc. announced that it expects to receive $12 million in funding - marketscreener.com
There Is A Reason Celularity Inc.'s (NASDAQ:CELU) Price Is Undemanding - simplywall.st
Celularity Inc. (GXGXW) Fundamental Analysis - Meyka
Celularity Inc. (CELU) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Market Outlook: Why Celularity Inc Equity Warrant stock is considered a top pickWeekly Trade Summary & Weekly Chart Analysis and Guides - moha.gov.vn
Celularity receives FDA warning over marketing claims - MSN
Celularity (NASDAQ:CELU) Trading 0.4% HigherShould You Buy? - MarketBeat
Celularity Shares Face Persistent Headwinds Amid Regulatory and Financial Challenges - AD HOC NEWS
Celularity Receives FDA Warning Over Marketing Claims - TipRanks
Celularity Inc Receives FDA Warning Letter - TradingView — Track All Markets
Is Celularity Inc. Equity Warrant stock attractive for ETFsTrade Volume Report & Growth Oriented Trade Recommendations - Newser
Will Celularity Inc. Equity Warrant stock benefit from commodity pricesWeekly Gains Summary & Growth Focused Stock Reports - Newser
Is Celularity Inc. Equity Warrant stock positioned for digital transformationMarket Performance Summary & Technical Confirmation Trade Alerts - Newser
Why analysts upgrade Celularity Inc. stockForecast Cut & Free Technical Pattern Based Buy Signals - Newser
Is Celularity Inc. Equity Warrant stock a safe investment in uncertain markets - Newser
Celularity (CELU) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
CELU announces CFO termination; appoints interim incharge - MSN
Celularity, Inc. Forms Death Cross, Signaling Potential Bearish Trend Ahead - Markets Mojo
[Form 4] Celularity Inc Insider Trading Activity - Stock Titan
Form 4: Celularity (CELU) director now holds 248,765 Class A shares - Stock Titan
Is Celularity Inc. Equity Warrant stock attractive after correctionWeekly Trading Summary & Expert Verified Movement Alerts - newser.com
Will Celularity Inc. Equity Warrant stock attract more institutional investors - newser.com
Is Celularity Inc a good long term investmentLarge Cap Stability Picks & Accelerated Capital Growth - earlytimes.in
Chart based analysis of Celularity Inc. Equity Warrant trendsQuarterly Profit Report & Safe Capital Preservation Plans - newser.com
Will Celularity Inc. Equity Warrant stock maintain momentum in 20252025 Year in Review & Real-Time Stock Entry Alerts - newser.com
Celularity Inc Azioni (CELU) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.08%
3.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):